about
Liver disease in cystic fibrosis: an updateSevere Kawasaki disease in a 3-month-old patient: a case report.Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients.High mobility group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate-severe asthma.HMGB1 values and response to HBV vaccine in children with celiac disease.SERUM YKL-40 IN CHILDREN WITH ASTHMA.EXHALED BREATH TEMPERATURE IN ASTHMATIC CHILDREN.YKL-40 as marker of severe lung disease in cystic fibrosis patients.Exhaled markers of anti-oxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease.Severe disease in Cystic Fibrosis and fecal calprotectin levels.HMGB1 as a new biomarker of celiac disease in children: A multicenter study.Zooming in on the ERS fellowships and the International Congress.Key paediatric messages from the 2018 European Respiratory Society International CongressSerum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotypeAntihistamines: ABC for the pediatriciansCetirizine use in childhood: an update of a friendly 30-year drugGeneral anesthesia, conscious sedation, or nothing: Decision-making by children during painful proceduresMinor pulmonary malformations in a childPilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory diseaseBacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: a pilot study on short-term efficacySuccessful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature reviewTargeted Therapy for Severe Asthma in Children and Adolescents: Current and Future PerspectivesMeasurement of nitric oxide and assessment of airway diseases in children: an updateGastroesophageal reflux and respiratory diseases: does a real link exist?Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheatNovel therapeutic targets for allergic airway disease in childrenOmalizumab treatment in a 12 year-old girl with chronic spontaneous urticariaSAFETY AND EFFICACY OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY TO HOUSE DUST MITE USING A DIFFERENT DOSAGE: A PILOT STUDY
P50
Q28662082-89CF3B91-6A56-4D61-88B5-8903CD5A9AFEQ34461943-449DBF2E-CCDE-4F1E-AD52-83E8C4F28D99Q35041801-19B65674-E0A5-4279-AA0F-D5436245572BQ38820414-675DFA40-9E4E-49BB-B727-E0FB9D0D9EADQ40058551-DAFEAD4E-938D-4A42-8B64-030BE950DB4CQ40244455-964D84FB-23FD-4DF5-9A98-81C8BCBFB4DAQ40244472-93666612-A159-4ED9-89A0-5F0F739B779FQ40829237-08B7A72B-ACBC-4229-814B-3BEEA79A6C60Q46259937-51173F54-2FA1-45E1-8512-9113758B5B32Q48012160-DFACDE7A-FDCF-497B-9ECA-80606EA59098Q51080607-5BB37DFE-57DF-441D-9CA5-5E09306E56AAQ55336155-0AE535AE-5B88-4528-A46D-4613787378A7Q64081136-F1C862C4-EB6A-435B-AC91-24CAAD7721D2Q86481335-DD663370-0C98-40A2-BCE5-DFDDFF93BA13Q89525133-1B3A6688-8E7B-4D1D-BCB8-338A5F5DF7ACQ90011431-0B626128-47A3-4363-8AAD-AE1996393F1CQ90859767-8F59411D-EAD7-46A1-AC36-654C657397CAQ91070839-777792C6-63E5-4B6A-9FE9-BF05697C6259Q91337724-DBB8D077-7118-4C5B-B91E-A6BAE2435C56Q91551286-12FE9B34-5727-40C3-8381-217AF31EE04BQ91649676-89FAAD51-CB79-40DB-B958-470E47D6E354Q92037673-BD00C54E-F3D4-4106-871A-6F175E8A8FDEQ92227923-2B451A62-628D-495E-AD1D-87FB7551DFE6Q92300961-15C89E62-AB44-4ADD-90B5-2B277613B4D1Q92354684-EE3E28C1-B5C0-40C1-A28A-5520D18F851CQ92485491-1863B78D-C3B5-4FF2-A053-8847C1CBBE6AQ93271534-B4808756-5E42-435C-9653-9D652C5AC188Q95508115-597D5F6A-9629-4657-85C8-CC8BE7FE7D11
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Giuseppe Fabio Parisi
@en
Giuseppe Fabio Parisi
@nl
type
label
Giuseppe Fabio Parisi
@en
Giuseppe Fabio Parisi
@nl
prefLabel
Giuseppe Fabio Parisi
@en
Giuseppe Fabio Parisi
@nl
P31
P496
0000-0003-4291-0195